The remaining 3 378 854 shares, equivalent to approximately 14,5 percent of the offered shares, have been allocated to shareholders and investors without preferential rights in accordance with the principles outlined in the prospectus dated June 12, 2017. Notification regarding allotment will be made through settlement notes to those who have been allotted shares. Payment of the shares should be made in accordance with the instructions on the settlement note. Interim shares (”BTA”) will be traded on AktieTorget until the rights issue is registered with the Swedish Companies Registration Office (Sw. Bolagsverket) after which time the interim shares will be exchanged for ordinary shares. This is expected in mid July 2017.
As a result of the rights issue, Sivers IMA will receive proceeds amounting to approximately MSEK 81,4 before transaction costs. Transaction costs to be deducted from the proceeds are estimated at MSEK 7,2 whereof MSEK 2,3 is guarantee provision.
As a result of the rights issue, Sivers IMAs share capital will increase by SEK 11 635 415,50 to SEK 46 541 663 and the total number of shares will increase by 23 270 831 shares to 93 083 326 shares.
For more information,
Tomas Duffy, Chairman of the board
Tel: +46 73 390 5280
This information is information that Sivers IMA is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 5 July 2017.
SIVERS IMA is a leading and internationally renowned supplier whose wholly owned subsidiaries Sivers IMA AB and CST Global Ltd develop, manufacture and sell cutting-edge chips, components, modules and subsystems based on proprietary advanced semiconductor technology in microwave, millimeterwave and optical semiconductors. Headquarters in Stockholm, Sweden. Sivers IMA Holding AB is traded on AktieTorget under ticker name SIVE. Learn more at http://siversima.com.